
Target dossiers
Disease associations, genetic evidence, tractability, safety, expression and known drugs for any gene or protein, from Open Targets and UniProt.
Drug discovery and DNA-based research
Pharmint Discover brings target biology, chemistry, structures, genetics and literature into one workspace. It is built entirely on permissively licensed public data, so every value on the screen can be traced back to the record it came from.
Start from a disease, a gene, a variant, a protein or a molecule. Each page is assembled from the same underlying records and links onward to the next.

Disease associations, genetic evidence, tractability, safety, expression and known drugs for any gene or protein, from Open Targets and UniProt.

Structure, physicochemical properties, drug-likeness, ADMET predictions, measured bioactivity and similar compounds across ChEMBL, PubChem and BindingDB.

Dock a ligand set against an experimental or predicted structure with AutoDock Vina and review ranked poses in the browser.

Follow a variant to its gene, its clinical significance and the targets it implicates, with ClinVar and GWAS Catalog evidence.

Translate, find ORFs, search Swiss-Prot and NCBI, design primers and score CRISPR guides against GRCh38.

Ask questions in plain language. The assistant queries the same data as every page and cites the record behind each answer.
The platform is validated by working pharmaceutical scientists. Their tools for doing that are part of the product, not an afterthought.
Each number links to the dataset, release and record it came from, so a claim can be checked in seconds.
Mark a value as correct, incorrect or questionable with a note. Flags land in a review queue and are answered.
Save targets, molecules and screens into projects shared with collaborators, with comments alongside the evidence.
Every dataset is public and commercially usable. Sources that carry attribution or share-alike terms are marked and handled accordingly. Gated databases are not used.
Access is by invitation while the platform is validated. Tell us who you are and what you are working on; an administrator will send an invite link.